ReviewFoods (Basel, Switzerland)2025
Carotenoid Yeasts and Their Application Potential.
Review in Foods (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Carotenoid production by Metschnikowia sp.: isolation from environmental samples and optimization of culture conditions.Biotechnology letters · 2026Article
- Sporobolomyces pararoseus: a versatile chassis for circular bioproduction of β-carotene, torulene, and torularhodin.Archives of microbiology · 2026Review
- Utilization of Quinoa Post-Fermentation Waste as a Medium for Carotenoid Production by Yeast.Molecules (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Carotenoids are part of a diverse group of isoprenoid compounds. Due to the many properties they possess, they may become an alternative to synthetic additives in various industrial sectors. The increase in consumer demand and awareness determines research into extracting them from plants, algae and microorganisms. The extraction of carotenoids from plants is an inefficient method and generates additional production costs. On the other hand, the carotenoid potential of microorganisms, especially among yeasts, has not been fully exploited. The diversity of yeast species and strains influences the extraction of many fractions of carotenoids, including the less known ones such as thorulene and tholuradine. The developed adaptability of yeast enables the optimisation of their culture, which facilitates the understanding of their metabolic pathways. At the same time, the coordination of carotenoid and lipid synthesis may prevent their degradation or the loss of their bioactive properties. Application research has been conducted mainly in the feed industry, where their colouring and antimicrobial or immunomodulating properties are used. In the medical and pharmaceutical fields, there is not much research due to safety restrictions and the necessity of the high purity of the fractions. This review also highlights the overlooked aspect of carotenoids' biodegradability, which is required to exploit the bioactive properties of microbial carotenoids.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.